26 results on '"Azimi V."'
Search Results
2. Robust multi objective H2/H∞ control of nonlinear uncertain systems using multiple linear model and ANFIS.
- Author
-
Azimi, V., Akhlaghi, P., and Kazemi, M.H.
- Published
- 2011
- Full Text
- View/download PDF
3. Synthesis of Phthalocyanine derivatives by synergistic effect of catalysts over nanodimensional zeolites under solvent-free conditions.
- Author
-
Yahyazadeh, A. and Azimi, V.
- Subjects
- *
PHTHALOCYANINE synthesis , *PHTHALOCYANINE derivatives , *ZEOLITES , *BENZENEDICARBONITRILE , *MASS spectrometry - Abstract
Copper (II) phthalocyanine and 2,9,16,23 tetrakis nitro copper (II) phthalocyaninehas been synthesized respectively from phthalonitrile and 4-nitro phthalonitrile under solvent-free condition using two different catalystsovernanodimensionalzeolites. 4-Nitro phthalonitrile synthesized from phthalimide in three steps. The newly prepared compounds have been characterized by IR, UV-Vis, 1HNMR and MS spectra. [ABSTRACT FROM AUTHOR]
- Published
- 2014
4. Histoire générale du droit et des institutions
- Author
-
Imbert, J., Jobert, Ph., Reulos, Salmonowicz, St., Kessler, Francis, Dravasa, E., Giordanengo, G., Sandras, R., Besnier, R., Lefebvre-Teillard, A., Waelkens, L., Kessler, F., Gaudemet, J., Azimi, V., and Poznański, Renée
- Published
- 1990
5. Information, communication, and modeling technologies in prosthetic leg and robotics research at Cleveland State University
- Author
-
Kondratenko, Y., Khademi, G., Azimi, V., Ebeigbe, D., Abdelhady, M., Fakoorian, S. A., Barto, T., Roshanineshat, A., Igor Atamanyuk, and Simon, D.
6. La régulation des pratiques contraignantes de soin en santé mentale : perspectives pour une approche interdisciplinaire
- Author
-
Aîdan, Géraldine, Béliard, Aude, Bellanger, Philippe, Cobbaut, Jean-Philippe, Doron, Claude-Olivier, Eyraud, Benoît, LE GOFF, Alice, Lechevalier Hurard, Lucie, Litzler, Alexandre, Marques, Ana, Moreau, Delphine, Protais, Caroline, Renaudie, Olivier, Saetta, Sébastien, Toppani, Anne, Velpry, Livia, Vidal-Naquet, Pierre, Centre d'Etudes et de Recherches de Sciences Administratives et Politiques ( CERSA ), Université Panthéon-Assas ( UP2 ) -Centre National de la Recherche Scientifique ( CNRS ), CERMES3 - Centre de recherche, médecine, sciences, santé, santé mentale, société ( CERMES3 - UM 7 (UMR 8211 / U988) ), Centre National de la Recherche Scientifique ( CNRS ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris Descartes - Paris 5 ( UPD5 ) -École des hautes études en sciences sociales ( EHESS ), Centre d’Ethique Médicale ( EA 4031 ), Université catholique de Lille ( UCL ) -Groupement hospitalier de l'Institut Catholique de Lille, SPHERE UMR 7219, Sciences - Philosophie - Histoire ( SPHERE ), Université Paris Diderot - Paris 7 ( UPD7 ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Paris Diderot - Paris 7 ( UPD7 ) -Centre National de la Recherche Scientifique ( CNRS ), Centre Max Weber ( CMW ), École normale supérieure - Lyon ( ENS Lyon ) -Université Lumière - Lyon 2 ( UL2 ) -Université Jean Monnet [Saint-Étienne] ( UJM ) -Centre National de la Recherche Scientifique ( CNRS ), CERLIS - Centre de recherche sur les liens sociaux - UMR 8070 ( CERLIS - UMR 8070 ), Centre National de la Recherche Scientifique ( CNRS ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Université Sorbonne Nouvelle - Paris 3, Université Paris Nanterre ( UPN ), EPS de Ville Evrard, L'Ecole des Hautes Etudes en Sciences Sociales ( EHESS ), École des hautes études en sciences sociales ( EHESS ) -School of Economics-Centre National de la Recherche Scientifique ( CNRS ), l'Observatoire français des drogues et des toxicomanies ( OFDT ), OFDT, Université Paris 8 Vincennes-Saint-Denis ( UP8 ), Cerpe, associé au Centre Max Weber ( CERPE ), Université Lumière - Lyon 2 ( UL2 ) -Université Lumière - Lyon 2 ( UL2 ), Azimi V., Hennion-Jacquet P., Koubi G., Centre d'Etudes et de Recherches de Sciences Administratives et Politiques (CERSA), Université Panthéon-Assas (UP2)-Centre National de la Recherche Scientifique (CNRS), CERMES3 - Centre de recherche Médecine, sciences, santé, santé mentale, société (CERMES3 - UMR 8211 / U988 / UM 7), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-École des hautes études en sciences sociales (EHESS), Centre d’Ethique Médicale (EA 4031), Université catholique de Lille (UCL)-Groupe Hospitalier de l'Institut Catholique de Lille (GHICL), Sciences, Philosophie, Histoire (SPHERE (UMR_7219)), Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Centre Max Weber (CMW), Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet [Saint-Étienne] (UJM), Centre de recherche sur les liens sociaux (CERLIS - UMR 8070), Université Sorbonne Nouvelle - Paris 3-Université Paris Descartes - Paris 5 (UPD5)-Centre National de la Recherche Scientifique (CNRS), Université Paris Nanterre (UPN), École des hautes études en sciences sociales (EHESS), l'Observatoire français des drogues et des toxicomanies (OFDT), Université Paris 8 Vincennes-Saint-Denis (UP8), Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet [Saint-Étienne] (UJM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet [Saint-Étienne] (UJM), Azimi V., Hennion-Jacquet P., Koubi G., Centre National de la Recherche Scientifique (CNRS)-Institut Cujas, Université Panthéon-Assas (UP2)-Université Panthéon-Assas (UP2), École des hautes études en sciences sociales (EHESS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre d’Ethique Médicale (CEM), Ethics on experiments, Transhumanism, Human Interactions, Care & Society (ETHICS EA 7446), Institut Catholique de Lille (ICL), Université catholique de Lille (UCL)-Université catholique de Lille (UCL)-Institut Catholique de Lille (ICL), Université catholique de Lille (UCL)-Université catholique de Lille (UCL), École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet - Saint-Étienne (UJM)-Centre National de la Recherche Scientifique (CNRS), École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet - Saint-Étienne (UJM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet - Saint-Étienne (UJM)-Centre National de la Recherche Scientifique (CNRS), Centre d'études et de recherches de science administrative (CERSA), Experiments, Technology, Human Interactions, Care & Society (ETHICS EA 7446), École normale supérieure de Lyon (ENS de Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet - Saint-Étienne (UJM)-Centre National de la Recherche Scientifique (CNRS), École normale supérieure de Lyon (ENS de Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet - Saint-Étienne (UJM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet - Saint-Étienne (UJM)-Centre National de la Recherche Scientifique (CNRS), and Velpry, Livia
- Subjects
santé mentale ,[SHS.SOCIO]Humanities and Social Sciences/Sociology ,contrainte ,[SHS.SOCIO] Humanities and Social Sciences/Sociology ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,consentement ,droit ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,[ SHS.SOCIO ] Humanities and Social Sciences/Sociology ,pratiques de soin ,justice - Abstract
International audience; Nous proposons dans cet article de préciser les contours d'un changement de paradigme dans la façon dont sont encadrées les pratiques en santé mentale, afin d'en dessiner les enjeux en terme de programme de recherche.
- Published
- 2015
7. Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine.
- Author
-
Lin Y, Farnsworth CW, Azimi V, Liss DB, Mullins ME, and Crews BO
- Abstract
Background: The increasing prevalence of xylazine in the illicit drug supply is a growing concern for major health consequences in individuals who use fentanyl mixed with xylazine, but limited data are available regarding the pharmacokinetics of xylazine in humans., Methods: Xylazine was quantified in serial remnant plasmas collected from 28 patients starting at the initial patient encounter and continuing for up to 52 h from presentation, using LC-MS/MS to calculate the terminal half-life for xylazine. Xylazine metabolites were identified by product ion scanning, and multiple reaction monitoring was used to estimate the relative abundance of xylazine metabolites in 74 collected plasma samples., Results: The median terminal half-life for xylazine was calculated to be 12.0 h (range: 5.9-20.8). Oxo-xylazine and sulfone-xylazine metabolites were detected in all plasma specimens that contained xylazine., Conclusions: The half-life of xylazine in humans is longer than previously observed in animal studies, which furthers the current understanding of the expected duration of effects in individuals who use fentanyl mixed with xylazine and the window of detection. Both oxo-xylazine and sulfone-xylazine appear to circulate in plasma for as long as xylazine., (© Association for Diagnostics & Laboratory Medicine 2024. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
8. Xylazine Positivity in Opioid-Positive Drug Screens on an Inpatient Labor Unit.
- Author
-
Trammel C, Azimi V, Crews B, Roper S, Raghuraman N, Carter EB, Frolova A, Odibo AO, Lawlor M, and Kelly JC
- Abstract
Objective: Untreated opioid use disorder (OUD) is associated with significant morbidity in pregnancy. Recent reports have highlighted the rise of xylazine in the nonprescribed fentanyl supply. The frequency with which pregnant people with OUD are exposed to xylazine has not been characterized. We sought to describe the rate of xylazine detection in urine drug screens (UDS) from pregnant people admitted to a labor unit., Methods: We performed a cross sectional study of all UDS results from an inpatient obstetric unit at an urban tertiary care center from December 2022, when xylazine was added to the detection panel, through July 2023. We perform universal verbal drug screening, with subsequent urine drug screening only performed after a positive verbal screen and consent. The trend of opioid-positive urine drug screens also positive for xylazine from December to July was measured with the Cochran-Armitage test., Results: Of 5662 people admitted to Labor and Delivery during the study period, 138 UDS were sent for 123 unique individuals. Ninety-eight (71%) of UDS were positive for nonprescribed substances. Of positive UDS, 36 (37%) were positive for nonprescribed opioids, and of these, 17 (47.2%) were positive for xylazine among 14 pregnant people. The trend of UDS positive for opioids that were also positive for xylazine increased significantly over time (P = 0.030), from 0% in December 2022 to 100% in July 2023., Conclusions: Over 8 months, xylazine positivity significantly increased in UDSs positive for nonprescribed opioids in an urban Midwestern hospital. These results underscore the critical need to study the impact of xylazine on obstetric outcomes., Competing Interests: The authors report no conflicts of interest., (Copyright © 2024 American Society of Addiction Medicine.)
- Published
- 2024
- Full Text
- View/download PDF
9. Automating the Detection of IV Fluid Contamination Using Unsupervised Machine Learning.
- Author
-
Spies NC, Hubler Z, Azimi V, Zhang R, Jackups R Jr, Gronowski AM, Farnsworth CW, and Zaydman MA
- Subjects
- Humans, Predictive Value of Tests, Workflow, Unsupervised Machine Learning
- Abstract
Background: Intravenous (IV) fluid contamination is a common cause of preanalytical error that can delay or misguide treatment decisions, leading to patient harm. Current approaches for detecting contamination rely on delta checks, which require a prior result, or manual technologist intervention, which is inefficient and vulnerable to human error. Supervised machine learning may provide a means to detect contamination, but its implementation is hindered by its reliance on expert-labeled training data. An automated approach that is accurate, reproducible, and practical is needed., Methods: A total of 25 747 291 basic metabolic panel (BMP) results from 312 721 patients were obtained from the laboratory information system (LIS). A Uniform Manifold Approximation and Projection (UMAP) model was trained and tested using a combination of real patient data and simulated IV fluid contamination. To provide an objective metric for classification, an "enrichment score" was derived and its performance assessed. Our current workflow was compared to UMAP predictions using expert chart review., Results: UMAP embeddings from real patient results demonstrated outliers suspicious for IV fluid contamination when compared with the simulated contamination's embeddings. At a flag rate of 3 per 1000 results, the positive predictive value (PPV) was adjudicated to be 0.78 from 100 consecutive positive predictions. Of these, 58 were previously undetected by our current clinical workflows, with 49 BMPs displaying a total of 56 critical results., Conclusions: Accurate and automatable detection of IV fluid contamination in BMP results is achievable without curating expertly labeled training data., (© Association for Diagnostics & Laboratory Medicine 2023. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
10. The relationship of testosterone levels with sprint performance in young professional track and field athletes.
- Author
-
Bezuglov E, Ahmetov II, Lazarev A, Mskhalaya G, Talibov O, Ustinov V, Shoshorina M, Bogachko E, Azimi V, Morgans R, and Hackney AC
- Subjects
- Humans, Male, Female, Athletes, Testosterone, Track and Field, Running, Athletic Performance
- Abstract
Evidence suggests that higher testosterone levels may provide an athletic advantage. Therefore, it is of practical interest to examine the association between testosterone levels and power- and strength-related traits in young professional track and field athletes, and to consider the factors that determine testosterone levels. The study involved 68 young professional athletes (45 females, 17.3 ± 2.6 years; 23 males, 18.2 ± 1.9 years). Testosterone levels were assessed via liquid chromatography-mass spectrometry. All subjects performed two 20 m and two 30 m sprint trials, and countermovement jump without arm-swing. A bioimpedance analysis of body composition was carried out and biological maturity was examined using the Khamis-Roche method. The average testosterone levels were 26.4 ± 9.6 nmol/l and 1.5 ± 0.7 nmol/l in males and females, respectively. In female athletes, testosterone levels did not correlate with any of traits. Males with the highest testosterone levels were significantly faster in the 20 m (p = 0.033) and 30 m (p = 0.014) sprint trials compared to males with lower testosterone levels. Testosterone levels in males were positively associated with fat mass (p = 0.027), and degree of biological maturation (p = 0.003). In conclusion, we found a positive relationship between testosterone levels and sprint performance in young male athletes., Competing Interests: Declaration of Competing Interest The authors report there are no competing interests to declare., (Copyright © 2023. Published by Elsevier Inc.)
- Published
- 2023
- Full Text
- View/download PDF
11. Organizational preparedness for the use of large language models in pathology informatics.
- Author
-
Hart SN, Hoffman NG, Gershkovich P, Christenson C, McClintock DS, Miller LJ, Jackups R, Azimi V, Spies N, and Brodsky V
- Abstract
In this paper, we consider the current and potential role of the latest generation of Large Language Models (LLMs) in medical informatics, particularly within the realms of clinical and anatomic pathology. We aim to provide a thorough understanding of the considerations that arise when employing LLMs in healthcare settings, such as determining appropriate use cases and evaluating the advantages and limitations of these models. Furthermore, this paper will consider the infrastructural and organizational requirements necessary for the successful implementation and utilization of LLMs in healthcare environments. We will discuss the importance of addressing education, security, bias, and privacy concerns associated with LLMs in clinical informatics, as well as the need for a robust framework to overcome regulatory, compliance, and legal challenges., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
12. Use of the Current Standard of Practice Serum Free Light Chains (sFLC) Reference Interval Puts Black Patients at 5 Times Higher Odds for Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS).
- Author
-
Azimi V, Fiala MA, and Zaydman MA
- Subjects
- Humans, Disease Progression, Immunoglobulin Light Chains, Black or African American, Monoclonal Gammopathy of Undetermined Significance diagnosis, Multiple Myeloma diagnosis
- Published
- 2023
- Full Text
- View/download PDF
13. A Single Reference Interval for Interpreting Serum Free Light Chains across Patients with Varying Renal Function.
- Author
-
Azimi V, Slade M, Fiala M, Fortier JM, Stockerl-Goldstein K, Frater JL, Brestoff JR, Jackups R, and Zaydman MA
- Abstract
Background: Serum free light chain (sFLC) assays are interpreted using a sFLC-ratio-based reference interval (manufacturer's interval) that was defined using a cohort of healthy patients. However, renal impairment elevates the sFLC-ratio, leading to a high false positive rate when using the manufacturer's interval. Prior studies have developed renal-specific reference intervals; however, this approach has not been widely adopted due to practical limitations. Thus, there remains a critical need for a renally robust sFLC interpretation method., Methods: Retrospective data mining was used to define patient cohorts that reflect the spectrum of renal function seen in clinical practice. Two new reference intervals, one based on the sFLC-ratio and one based on a novel principal component analysis (PCA)-based metric, were developed for the FREELITE assay (Binding Site) on the Roche Cobas c501 instrument (Roche)., Results: Compared to the manufacturer's reference interval, both new methods exhibited significantly lower false positive rates and greater robustness to renal function while maintaining equivalent sensitivity for monoclonal gammopathy (MG) diagnosis. While not significantly different, the point estimate for sensitivity was highest for the PCA-based approach., Conclusion: Renally robust sFLC interpretation using a single reference interval is possible given a reference cohort that reflects the variation in renal function observed in practice. Further studies are needed to achieve sufficient power and determine if the novel PCA-based metric offers superior sensitivity for MG diagnosis. These new methods offer the practical advantages of not requiring an estimated glomerular filtration rate result or multiple reference intervals, thereby lowering practical barriers to implementation., (© American Association for Clinical Chemistry 2023.)
- Published
- 2023
- Full Text
- View/download PDF
14. Optimizing Equity: Working towards Fair Machine Learning Algorithms in Laboratory Medicine.
- Author
-
Azimi V and Zaydman MA
- Subjects
- Humans, Algorithms, Laboratories, Bias, Machine Learning, Delivery of Health Care
- Abstract
Background: Methods of machine learning provide opportunities to use real-world data to solve complex problems. Applications of these methods in laboratory medicine promise to increase diagnostic accuracy and streamline laboratory operations leading to improvement in the quality and efficiency of healthcare delivery. However, machine learning models are vulnerable to learning from undesirable patterns in the data that reflect societal biases. As a result, irresponsible application of machine learning may lead to the perpetuation, or even amplification, of existing disparities in healthcare outcomes., Content: In this work, we review what it means for a model to be unfair, discuss the various ways that machine learning models become unfair, and present engineering principles emerging from the field of algorithmic fairness. These materials are presented with a focus on the development of machine learning models in laboratory medicine., Summary: We hope that this work will serve to increase awareness, and stimulate further discussion, of this important issue among laboratorians as the field moves forward with the incorporation of machine learning models into laboratory practice., (© American Association for Clinical Chemistry 2023. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
15. Comparison of the Friedewald equation with Martin and Sampson equations for estimating LDL cholesterol in hypertriglyceridemic adults.
- Author
-
Azimi V, Farnsworth CW, and Roper SM
- Subjects
- Adult, Cholesterol, LDL, Humans, Retrospective Studies, Triglycerides, Hypertriglyceridemia
- Abstract
Low density lipoprotein cholesterol (LDL-C) is traditionally calculated using the Friedewald (LDL-F) equation. New equations by Martin (LDL-M) and Sampson (LDL-S) have improved accuracy relative to LDL-F for samples with high triglycerides (TG) or low LDL-C. However, most labs still rely on LDL-F and few studies have examined the accuracy and impact of contemporary LDL-C equations applied to a retrospective dataset. 934 lipid panels with a concurrent direct enzymatic LDL-C (dLDL-C) result were extracted from the laboratory information system. LDL-F, LDL-M, and LDL-S were calculated and the accuracy of each equation determined in a predominantly hypertriglyceridemic population. The impact of implementing each equation was compared by analyzing the LDL-C treatment group miscategorization rate relative to dLDL-C. The slope for the LDL-F, LDL-M and LDL-S were 0.59, 0.78, and 0.94, relative to dLDL-C. The three equations performed comparably for samples with TG <4.52 mmol/L (<400 mg/dL). The LDL-C treatment group miscategorization rate was 48.6 % for LDL-F, 28.8 % for LDL-M and 37.2 % for LDL-S in specimens with TG ≥4.52 mmol/L (≥400 mg/dL) (n = 817). LDL-S underestimated treatment group category (31.3 %, 95 % CI 17.2-22.4) relative to LDL-M (9.0 %, 4.39-7.41, P < 0.001). 5.9 % of samples were overestimated for treatment group category by LDL-S vs 19.8 % for LDL-M (P = 0.1883). LDL-M and LDL-S demonstrate reduced bias with a dLDL-C method compared to LDL-F in samples with TG ≥4.52 mmol/L (≥400 mg/dL). LDL-M reduces LDL-C treatment group miscategorization rate leading to fewer underestimations of risk overall compared to LDL-S; however, neither may be sufficiently accurate to report LDL-C in patients with TG ≥4.52 mmol/L (≥400 mg/dL)., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
16. Use of laboratory data for illicit drug use surveillance and identification of socioeconomic risk factors.
- Author
-
Azimi V, Jackups R Jr, Farnsworth CW, and Budelier MM
- Subjects
- Fentanyl, Humans, Risk Factors, Socioeconomic Factors, United States epidemiology, COVID-19 epidemiology, Cocaine, Drug Overdose epidemiology, Illicit Drugs, Substance-Related Disorders
- Abstract
Background: Drug overdose is the leading cause of death among people 25-44 years of age in the United States. Existing drug surveillance methods are important for prevention and directing treatment, but are limited by delayed reporting and lack of geographic granularity., Methods: Laboratory urine drug screen and complete metabolic panel data from patients presenting to the emergency department was used to observe long-term and short-term temporal and geospatial changes at the zip code-level in St. Louis. Multivariate linear regression was performed to investigate associations between zip code-level socioeconomic factors and drug screening positivity rates., Results: An increase in the fentanyl positive drug screens was seen during the initial COVID-19 shutdown period in the spring of 2020. A decrease in cocaine positivity was seen in the fall and winter of 2020, with a return to baseline coinciding with the second major COVID-19 shutdown in the summer of 2021. These changes appeared to be independent of changes in emergency department utilization as measured by complete metabolic panels ordered. Significant short-term changes in fentanyl and cocaine positivity rates between specific time periods were able to be localized to individual zip codes. Zip code-level multivariate analysis demonstrated independent associations between socioeconomic/demographic factors and fentanyl/cocaine positivity rates as determined by laboratory drug screening data., Conclusions: Analyzing clinical laboratory drug screening data can enable a more temporally and geographically granular view of population-level drug use surveillance. Additionally, laboratory data can be utilized to find population-level socioeconomic associations with illicit drug use, presenting a potential avenue for the use of this data to guide public health and healthcare policy decisions., (Copyright © 2022. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
17. Persistent Elevation of Serum Human Chorionic Gonadotropin in a Nonpregnant Woman.
- Author
-
Azimi V and Gronowski AM
- Subjects
- Female, Humans, Chorionic Gonadotropin blood
- Published
- 2022
- Full Text
- View/download PDF
18. Decreased Renal Function Is Associated with Mild Elevations of hCG in Women >40 Years of Age.
- Author
-
Azimi V, Budelier MM, and Gronowski AM
- Subjects
- Female, Humans, Kidney physiology, Chorionic Gonadotropin, Follicle Stimulating Hormone
- Published
- 2021
- Full Text
- View/download PDF
19. State estimation-based control of COVID-19 epidemic before and after vaccine development.
- Author
-
Rajaei A, Raeiszadeh M, Azimi V, and Sharifi M
- Abstract
In this study, a nonlinear robust control policy is designed together with a state observer in order to manage the novel coronavirus disease (COVID-19) outbreak having an uncertain epidemiological model with unmeasurable variables. This nonlinear model for the COVID-19 epidemic includes eight state variables (susceptible, exposed, infected, quarantined, hospitalized, recovered, deceased, and insusceptible populations). Two plausible scenarios are put forward in this article to control this epidemic before and after its vaccine invention. In the first scenario, the social distancing and hospitalization rates are employed as two applicable control inputs to diminish the exposed and infected groups. However, in the second scenario after the vaccine development, the vaccination rate is taken into account as the third control input to reduce the susceptible populations, in addition to the two objectives of the first scenario. The proposed feedback control measures are defined in terms of the hospitalized and deceased populations due to the available statistical data, while other unmeasurable compartmental variables are estimated by an extended Kalman filter (EKF). In other words, the susceptible, exposed, infected, quarantined, recovered, and insusceptible individuals cannot be identified precisely because of the asymptomatic infection of COVID-19 in some cases, its incubation period, and the lack of an adequate community screening. Utilizing the Lyapunov theorem, the stability and bounded tracking convergence of the closed-loop epidemiological system are investigated in the presence of modeling uncertainties. Finally, a comprehensive simulation study is conducted based on Canada's reported cases for two defined timing plans (with different treatment rates). Obtained results demonstrate that the developed EKF-based control scheme can achieve desired epidemic goals (exponential decrease of infected, exposed, and susceptible people)., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
20. Was the Iron Profile Really Incomplete?
- Author
-
Azimi V, Tang MS, and Budelier MM
- Subjects
- Humans, Iron metabolism, Transferrin
- Published
- 2021
- Full Text
- View/download PDF
21. An Extensive Set of Kinematic and Kinetic Data for Individuals with Intact Limbs and Transfemoral Prosthesis Users.
- Author
-
Fakoorian S, Roshanineshat A, Khalaf P, Azimi V, Simon D, and Hardin E
- Abstract
This paper introduces an extensive human motion data set for typical activities of daily living. These data are crucial for the design and control of prosthetic devices for transfemoral prosthesis users. This data set was collected from seven individuals, including five individuals with intact limbs and two transfemoral prosthesis users. These data include the following types of movements: (1) walking at three different speeds; (2) walking up and down a 5-degree ramp; (3) stepping up and down; (4) sitting down and standing up. We provide full-body marker trajectories and ground reaction forces (GRFs) as well as joint angles, joint velocities, joint torques, and joint powers. This data set is publicly available at the website referenced in this paper. Data from flexion and extension of the hip, knee, and ankle are presented in this paper. However, the data accompanying this paper (available on the internet) include 46 distinct measurements and can be useful for validating or generating mathematical models to simulate the gait of both transfemoral prosthesis users and individuals with intact legs., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2020 Seyed Fakoorian et al.)
- Published
- 2020
- Full Text
- View/download PDF
22. Robust Cell Detection and Segmentation for Image Cytometry Reveal Th17 Cell Heterogeneity.
- Author
-
Tsujikawa T, Thibault G, Azimi V, Sivagnanam S, Banik G, Means C, Kawashima R, Clayburgh DR, Gray JW, Coussens LM, and Chang YH
- Subjects
- Carcinoma, Pancreatic Ductal diagnosis, Carcinoma, Pancreatic Ductal immunology, Carcinoma, Pancreatic Ductal pathology, Cell Nucleus pathology, Diagnosis, Differential, Head and Neck Neoplasms diagnosis, Head and Neck Neoplasms immunology, Head and Neck Neoplasms pathology, Hematoxylin chemistry, Humans, Immunohistochemistry, Lung Neoplasms diagnosis, Lung Neoplasms immunology, Lung Neoplasms pathology, Mesothelioma diagnosis, Mesothelioma immunology, Mesothelioma pathology, Mesothelioma, Malignant, Pancreatic Neoplasms diagnosis, Pancreatic Neoplasms immunology, Pancreatic Neoplasms pathology, Pleural Neoplasms diagnosis, Pleural Neoplasms immunology, Pleural Neoplasms pathology, Prognosis, Reproducibility of Results, Sensitivity and Specificity, Squamous Cell Carcinoma of Head and Neck diagnosis, Squamous Cell Carcinoma of Head and Neck immunology, Squamous Cell Carcinoma of Head and Neck pathology, Th17 Cells cytology, Tumor Microenvironment immunology, Algorithms, Image Cytometry methods, Image Interpretation, Computer-Assisted methods, Single-Cell Analysis methods, Th17 Cells pathology
- Abstract
Image cytometry enables quantitative cell characterization with preserved tissue architecture; thus, it has been highlighted in the advancement of multiplex immunohistochemistry (IHC) and digital image analysis in the context of immune-based biomarker monitoring associated with cancer immunotherapy. However, one of the challenges in the current image cytometry methodology is a technical limitation in the segmentation of nuclei and cellular components particularly in heterogeneously stained cancer tissue images. To improve the detection and specificity of single-cell segmentation in hematoxylin-stained images (which can be utilized for recently reported 12-biomarker chromogenic sequential multiplex IHC), we adapted a segmentation algorithm previously developed for hematoxlin and eosin-stained images, where morphological features are extracted based on Gabor-filtering, followed by stacking of image pixels into n-dimensional feature space and unsupervised clustering of individual pixels. Our proposed method showed improved sensitivity and specificity in comparison with standard segmentation methods. Replacing previously proposed methods with our method in multiplex IHC/image cytometry analysis, we observed higher detection of cell lineages including relatively rare T
H 17 cells, further enabling sub-population analysis into TH 1-like and TH 2-like phenotypes based on T-bet and GATA3 expression. Interestingly, predominance of TH 2-like TH 17 cells was associated with human papilloma virus (HPV)-negative status of oropharyngeal squamous cell carcinoma of head and neck, known as a poor-prognostic subtype in comparison with HPV-positive status. Furthermore, TH 2-like TH 17 cells in HPV-negative head and neck cancer tissues were spatiotemporally correlated with CD66b+ granulocytes, presumably associated with an immunosuppressive microenvironment. Our cell segmentation method for multiplex IHC/image cytometry potentially contributes to in-depth immune profiling and spatial association, leading to further tissue-based biomarker exploration. © 2019 International Society for Advancement of Cytometry., (© 2019 International Society for Advancement of Cytometry.)- Published
- 2019
- Full Text
- View/download PDF
23. Deep learning based Nucleus Classification in pancreas histological images.
- Author
-
Young Hwan Chang, Thibault G, Madin O, Azimi V, Meyers C, Johnson B, Link J, Margolin A, and Gray JW
- Subjects
- Cell Nucleus, Genomics, Machine Learning
- Abstract
Tumor specimens contain a variety of healthy cells as well as cancerous cells, and this heterogeneity underlies resistance to various cancer therapies. But this problem has not been thoroughly investigated until recently. Meanwhile, technological breakthroughs in imaging have led to an explosion of molecular and cellular profiling data from large numbers of samples, and modern machine learning approaches including deep learning have been shown to produce encouraging results by finding hidden structures and make accurate predictions. In this paper, we propose a Deep learning based Nucleus Classification (DeepNC) approach using paired histopathology and immunofluorescence images (for label), and demonstrate its classification prediction power. This method can solve current issue on discrepancy between genomic- or transcriptomic-based and pathology-based tumor purity estimates by improving histological evaluation. We also explain challenges in training a deep learning model for huge dataset.
- Published
- 2017
- Full Text
- View/download PDF
24. Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis.
- Author
-
Tsujikawa T, Kumar S, Borkar RN, Azimi V, Thibault G, Chang YH, Balter A, Kawashima R, Choe G, Sauer D, El Rassi E, Clayburgh DR, Kulesz-Martin MF, Lutz ER, Zheng L, Jaffee EM, Leyshock P, Margolin AA, Mori M, Gray JW, Flint PW, and Coussens LM
- Subjects
- Aged, Aged, 80 and over, Biomarkers, Tumor metabolism, Cohort Studies, Female, Humans, Immunohistochemistry, Male, Middle Aged, Prognosis, Statistics, Nonparametric, Tissue Array Analysis, Biomarkers, Tumor analysis, Carcinoma, Squamous Cell immunology, Head and Neck Neoplasms immunology, Image Cytometry methods, Image Processing, Computer-Assisted, Monitoring, Immunologic methods
- Abstract
Here, we describe a multiplexed immunohistochemical platform with computational image processing workflows, including image cytometry, enabling simultaneous evaluation of 12 biomarkers in one formalin-fixed paraffin-embedded tissue section. To validate this platform, we used tissue microarrays containing 38 archival head and neck squamous cell carcinomas and revealed differential immune profiles based on lymphoid and myeloid cell densities, correlating with human papilloma virus status and prognosis. Based on these results, we investigated 24 pancreatic ductal adenocarcinomas from patients who received neoadjuvant GVAX vaccination and revealed that response to therapy correlated with degree of mono-myelocytic cell density and percentages of CD8
+ T cells expressing T cell exhaustion markers. These data highlight the utility of in situ immune monitoring for patient stratification and provide digital image processing pipelines to the community for examining immune complexity in precious tissue sections, where phenotype and tissue architecture are preserved to improve biomarker discovery and assessment., (Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
25. BREAST CANCER HISTOPATHOLOGY IMAGE ANALYSIS PIPELINE FOR TUMOR PURITY ESTIMATION.
- Author
-
Azimi V, Chang YH, Thibault G, Smith J, Tsujikawa T, Kukull B, Jensen B, Corless C, Margolin A, and Gray JW
- Abstract
The translation of genomic sequencing technology to the clinic has greatly advanced personalized medicine. However, the presence of normal cells in tumors is a confounding factor in genome sequence analysis. Tumor purity, or the percentage of cancerous cells in whole tissue section, is a correction factor that can be used to improve the clinical utility of genomic sequencing. Currently, tumor purity is estimated visually by expert pathologists; however, it has been shown that there exist vast inter-observer discrepancies in tumor purity scoring. In this paper, we propose a quantitative image analysis pipeline for tumor purity estimation and provide a systematic comparison between pathologists' scores and our image-based tumor purity estimation.
- Published
- 2017
- Full Text
- View/download PDF
26. Quantitative analysis of histological tissue image based on cytological profiles and spatial statistics.
- Author
-
Young Hwan Chang, Thibault G, Azimi V, Johnson B, Jorgens D, Link J, Margolin A, and Gray JW
- Subjects
- Eosine Yellowish-(YS), Hematoxylin, Humans, Spatial Analysis, Cell Nucleus, Staining and Labeling
- Abstract
The cellular heterogeneity and complex tissue architecture of most tumor samples is a major obstacle in image analysis on standard hematoxylin and eosin-stained (H&E) tissue sections. A mixture of cancer and normal cells complicates the interpretation of their cytological profiles. Furthermore, spatial arrangement and architectural organization of cells are generally not reflected in cellular characteristics analysis. To address these challenges, first we describe an automatic nuclei segmentation of H&E tissue sections. In the task of deconvoluting cellular heterogeneity, we adopt Landmark based Spectral Clustering (LSC) to group individual nuclei in such a way that nuclei in the same group are more similar. We next devise spatial statistics for analyzing spatial arrangement and organization, which are not detectable by individual cellular characteristics. Our quantitative, spatial statistics analysis could benefit H&E section analysis by refining and complementing cellular characteristics analysis.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.